Roger D. Kouyos

Also affiliated with University Hospital of Zurich

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

0.986Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study

Swiss Medical Weekly(2022)10.4414/smw.2022.w30192

Top 28%

0.724DataRank

Top 28%15 citations

Frédérique Hovaguimian, Roger D. Kouyos, Axel J. Schmidt, Enos Bernasconi, Dominique L. Braun +20 more

Papers

Driven by 54 papers — median percentile 41. Top paper: “Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia”.

Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia

Clinical Infectious Diseases(2024)10.1093/cid/ciae261

N/A

0.837DataRank · unranked

18 citations

Jacqueline Huwa, Guy Muula, Geldert Chiwaya, E. de la Banda, Shameem Buleya +11 more

Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study

Swiss Medical Weekly(2022)10.4414/smw.2022.w30192

Top 28%

0.724DataRank

Top 28%15 citations

Frédérique Hovaguimian, Roger D. Kouyos, Axel J. Schmidt, Enos Bernasconi, Dominique L. Braun +20 more

Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy

Clinical Infectious Diseases(2023)10.1093/cid/ciad286

N/A

0.590DataRank · unranked

50 citations

Frédérique Chammartin, José Damas, Alexandra Calmy, David Haerry, M Stöckle +54 more

External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

Journal of Hepatology(2023)10.1016/j.jhep.2022.12.029

N/A

0.434DataRank · unranked

17 citations

Adrià Ramírez Mena, Marie Roumet, Andreas Limacher, Colette Smit, Olivier Leleux +91 more

Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study

Clinical Infectious Diseases(2023)10.1093/cid/ciad033

N/A

0.371DataRank · unranked

8 citations

Julia N Kleynhans, Bruno Ledergerber, Isabella C Schoepf, Christian W. Thorball, Neeltje A. Kootstra +57 more

Recommendations on data sharing in HIV drug resistance research

PLOS Medicine(2023)10.1371/journal.pmed.1004293

N/A

0.360DataRank · unranked

10 citations

Mark J. Siedner, Susan J. Little, Santiago Ávila‐Ríos, Alisen Ayitewala, Ronald J. Bosch +50 more

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST)

BMJ Open(2024)10.1136/bmjopen-2024-085819

N/A

0.292DataRank · unranked

6 citations

Mamatha Sauermann, Tom Loosli, Stefanie Hossmann, Selma Riedo, Niko Beerenwinkel +7 more

HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies

medRxiv(2023)10.1101/2023.04.05.23288183

Top 59%

0.261DataRank

Top 59%3 citations

Stefanie Hossmann, Suzanne M Ingle, Hajra Okhai, Katharina Kusejko, Johannes P. Mouton +13 more

Viral and Immune Risk Factors of HIV Rebound After Interruption of Antiretroviral Therapy

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae585

N/A

0.247DataRank · unranked

3 citations

Tingting Yu, Ran Wang, Caroline Ignacio, Merle Schanz, Roger D. Kouyos +11 more

Self-reported neurocognitive complaints in the Swiss HIV Cohort Study: a viral genome-wide association study

Brain Communications(2024)10.1093/braincomms/fcae188

N/A

0.208DataRank · unranked

3 citations

Chloé Pasin, Matthias Cavassini, Mélanie Bieler-Aeschlimann, Paul Frischknecht, Katharina Kusejko +60 more

Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae291

N/A

0.208DataRank · unranked

3 citations

Frédérique Chammartin, Annette Audigé, Anna Eichenberger, Dominique L. Braun, Patrizia Amico +84 more

Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C

PLoS Computational Biology(2021)10.1371/journal.pcbi.1008363

N/A

0DataRank · unranked

7 citations

Gert U. van Zyl, Hesam Montazeri, Jack Kuipers, Soo‐Yon Rhee, Roger D. Kouyos +3 more

Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesis

Journal of Clinical Epidemiology(2022)10.1016/j.jclinepi.2022.02.005

N/A

0DataRank · unranked

32 citations

Fardo Goldstein, Martina L. Reichmuth, Roger D. Kouyos, Gilles Wandeler, Matthias Egger +2 more

Dolutegravir Monotherapy as Maintenance Strategy: A Meta-Analysis of Individual Participant Data From Randomized Controlled Trials

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac107

N/A

0DataRank · unranked

15 citations

Laurent Hocqueloux, Dominique L. Braun, Karin J. Metzner, Roger D. Kouyos, François Raffi +9 more

Identifying Contact Risks for SARS-CoV-2 Transmission to Healthcare Workers during Outbreak on COVID-19 Ward

Emerging infectious diseases(2022)10.3201/eid2810.220266

N/A

0DataRank · unranked

6 citations

Dana Weissberg, Silvana K. Rampini, Rouven Müller, Thomas Scheier, Walter Zingg +3 more

HIV-phyloTSI: Subtype-independent estimation of time since HIV-1 infection for cross-sectional measures of population incidence using deep sequence data

medRxiv(2022)10.1101/2022.05.15.22275117

N/A

0DataRank · unranked

9 citations

Lucie Abeler‐Dörner, Matthew Hall, Chris Wymant, David Bonsall, George MacIntyre-Cockett +44 more

Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Clinical Infectious Diseases(2022)10.1093/cid/ciac242

N/A

0DataRank · unranked

1 citations

Benjamin Hampel, David García Núñez, Manuel Battegay, Anna Hachfeld, Enos Bernasconi +15 more

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

The Lancet HIV(2023)10.1016/s2352-3018(23)00228-x

N/A

0DataRank · unranked

130 citations

Stefanie Hossmann, Suzanne M Ingle, Hajra Okhai, Katharina Kusejko, Johannes P. Mouton +13 more

Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

The Lancet Regional Health - Europe(2023)10.1016/j.lanepe.2023.100793

N/A

0DataRank · unranked

51 citations

Susana Alves Saldanha, Fabian Schaller, Eva Choong, Aline Munting, Matthias Cavassini +65 more

Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1

Journal of Antimicrobial Chemotherapy(2023)10.1093/jac/dkac430

N/A

0DataRank · unranked

18 citations

Tom Loosli, Maryam Zaheri, Paul Frischknecht, Michael Huber, Katharina Kusejko +19 more

Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad292

N/A

0DataRank · unranked

12 citations

Jasmin Tschumi, Marius Zeeb, Christine Leemann, Corinne D Schenkel, Kathrin Neumann +12 more

Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad150

N/A

0DataRank · unranked

9 citations

Frédérique Chammartin, Irène A. Abela, Patrizia Amico, Marcel Stoeckle, Anna Eichenberger +85 more

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad197

N/A

0DataRank · unranked

4 citations

Anthony Hauser, Irène A. Abela, Chloé Pasin, Selina Epp, Tsepang Mohloanyane +6 more

Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100485

N/A

0DataRank · unranked

4 citations

Yuepeng Zhang, Julian Spagnuolo, Alexander Thielen, Martin Däumer, Carsten Wiethe +58 more

Mycobacterium tuberculosis infection associated immune perturbations correlate with antiretroviral immunity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.14.548872

N/A

0DataRank · unranked

1 citations

Lisa Jörimann, Corinne D Schenkel, Lennart Opitz, Jasmin Tschumi, Rebekka Wolfensberger +21 more

Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae014

N/A

0DataRank · unranked

41 citations

Jessy J. Duran Ramirez, Maxime Hentzien, Matthias Cavassini, Enos Bernasconi, Eveline Hofmann +55 more

Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies

The Journal of Experimental Medicine(2024)10.1084/jem.20240365

N/A

0DataRank · unranked

39 citations

Nina K. Mair, Irène A. Abela, Kevin Groen, Roger Kuratli, Marie Lork +59 more

HIV-1 Low-Level Viremia Predicts Viral Failure in Participants on Antiretroviral Therapy in the Swiss HIV Cohort Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae569

N/A

0DataRank · unranked

14 citations

J.H. Meier, Marcel Stoeckle, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini +55 more

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection

mBio(2024)10.1128/mbio.02722-23

N/A

0DataRank · unranked

11 citations

Magdalena Schwarzmüller, Agnė Ulytė, Thomas Radtke, Sarah R. Haile, Priska Ammann +20 more

Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral Therapy

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003388

N/A

0DataRank · unranked

4 citations

Marco Labarile, Dominique L. Braun, Andri Rauch, M Stöckle, Matthias Cavassini +9 more

Impact of hormonal therapy on HIV‐1 immune markers in cis women and gender minorities

HIV Medicine(2024)10.1111/hiv.13677

N/A

0DataRank · unranked

5 citations

David García Núñez, Katharina Kusejko, Anna Hachfeld, Hélène Buvelot, Matthias Cavassini +11 more

Circulating HBV RNA and Hepatitis B Core–Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae189

N/A

0DataRank · unranked

2 citations

Anders Boyd, Marie‐Laure Plissonnier, Barbara Testoni, Luisa Salazar‐Vizcaya, Franziska Suter‐Riniker +60 more

Transcriptional profile of Mycobacterium tuberculosis infection in people living with HIV

iScience(2024)10.1016/j.isci.2024.111228

N/A

0DataRank · unranked

2 citations

Lisa Jörimann, Corinne D Schenkel, Lennart Opitz, Jasmin Tschumi, Rebekka Wolfensberger +21 more

Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen

PLoS Pathogens(2024)10.1371/journal.ppat.1012385

N/A

0DataRank · unranked

2 citations

Marius Zeeb, Christian W. Thorball, Jacques Fellay, Karin J. Metzner, Paul Frischknecht +15 more

Predicting emergent Dolutegravir resistance in South Africa: A modelling study

medRxiv(2024)10.1101/2024.07.20.24310740

N/A

0DataRank · unranked

1 citations

Anthony Hauser, Johannes Josi, Na Han, Suzanne M Ingle, Ard van Sighem +12 more

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae002

N/A

0DataRank · unranked

0 citations

Anthony Hauser, Magdalena Schwarzmüller, Chloé Pasin, Katharina Kusejko, Selina Epp +62 more

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre longitudinal study (DTG RESIST)

medRxiv(2024)10.1101/2024.05.23.24307850

N/A

0DataRank · unranked

0 citations

Mamatha Sauermann, Tom Loosli, Stefanie Hossmann, Selma Riedo, Niko Beerenwinkel +7 more

Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling study

The Lancet Global Health(2025)10.1016/s2214-109x(24)00553-9

N/A

0DataRank · unranked

25 citations

Na Han, Anthony Hauser, Johannes Josi, Suzanne M Ingle, Ard van Sighem +12 more

The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study

The Lancet Global Health(2025)10.1016/s2214-109x(25)00350-x

N/A

0DataRank · unranked

3 citations

Tom Loosli, Nanina Anderegg, Anthony Hauser, Johannes Josi, Mary‐Ann Davies +6 more

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Cell Host & Microbe(2025)10.1016/j.chom.2025.01.004

N/A

0DataRank · unranked

3 citations

Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer L. Mamrosh, Samuel Mundia Kariuki +33 more

Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence

Clinical Infectious Diseases(2025)10.1093/cid/ciaf444

N/A

0DataRank · unranked

2 citations

Richard Lessells, Winnie Muyindike, Lyra S. Johnson, Roger D. Kouyos, Tom Loosli +10 more

Inflammation and B cell activation define a plasma proteome signature predicting tuberculosis in people with HIV

mBio(2025)10.1128/mbio.01585-25

N/A

0DataRank · unranked

1 citations

Mohammad Arefian, Diane Duroux, Marius Zeeb, Cédric Dollé, Matthias Hoffmann +12 more

Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function

PLoS ONE(2025)10.1371/journal.pone.0317965

N/A

0DataRank · unranked

0 citations

Alain Amstutz, Macé M. Schuurmans, Patrizia Amico, Dominique L. Braun, Marcel Stoeckle +21 more

The genetic architecture of HIV-1 virulence

Virus Evolution(2025)10.1093/ve/veaf057

Top 100%

0DataRank

Top 100%0 citations

Chris Wymant, Matthew Hall, Robert A. Power, Tanya Golubchik, Astrid Gall +28 more

Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study

PLoS Medicine(2020)10.1371/journal.pmed.1003397

N/A

0DataRank · unranked

19 citations

Katharina Kusejko, Leigh F. Johnson, Huldrych F. Gunthard, Julien Riou, Gilles Wandeler +3 more

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1614

N/A

0DataRank · unranked

44 citations

Alexandra Scherrer, Roger D. Kouyos, Michael Huber, Hans H. Hirsch, Matthieu Perreau +49 more

The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1839

N/A

0DataRank · unranked

42 citations

Álvaro Auñón, Bernhard Jost, Benito Natividad, Carol Strahm, Christine Thurnheer +24 more

Quantifying variation in bacterial reproductive fitness with and without antimicrobial resistance: a high-throughput method

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.13.093807

N/A

0DataRank · unranked

0 citations

Julian Baer, Judith Bergadà Pijuan, Conor Lawless, Philipp Bühler, Roger D. Kouyos +4 more

Quantifying Variation in Bacterial Reproductive Fitness: a High-Throughput Method

mSystems(2021)10.1128/msystems.01323-20

N/A

0DataRank · unranked

40 citations

Julian Baer, Judith Bergadà-Pijuan, Conor Lawless, Philipp Bühler, Roger D. Kouyos +4 more

Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab032

N/A

0DataRank · unranked

28 citations

Matthias Cavassini, Marie Paule Schneider, Hansjakob Furrer, Alexandra Calmy, Manuel Battegay +51 more

HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection

JCI Insight(2021)10.1172/jci.insight.143940

N/A

0DataRank · unranked

21 citations

Valentina Vongrad, Sandra E Chaudron, Mohaned Shilaih, Christine Leemann, Kathrin Neumann +8 more

Coronary Artery Disease–Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study

Clinical Infectious Diseases(2021)10.1093/cid/ciab521

N/A

0DataRank · unranked

13 citations

Christian W. Thorball, Bruno Ledergerber, Tanja Engel, Marieke Raffenberg, Neeltje A. Kootstra +65 more

Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study

PLoS Computational Biology(2021)10.1371/journal.pcbi.1009529

N/A

0DataRank · unranked

9 citations

Luisa Salazar‐Vizcaya, Axel J. Schmidt, Viacheslav N. Kachalov, Katharina Kusejko, Maria Christine Thurnheer +11 more

Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Clinical Infectious Diseases(2021)10.1093/cid/ciab628

N/A

0DataRank · unranked

7 citations

Benjamin Hampel, David García Núñez, Manuel Battegay, Anna Hachfeld, Enos Bernasconi +56 more

Roger D. Kouyos

Indexed papers

Top data-sharing exemplar

Papers